A practical strategy to use the ICD-11 for morbidity coding in the United States without a clinical modification
Kin Wah Fung(National Institutes of Health), Olivier Bodenreider(United States National Library of Medicine), Julia Xu(University of Pittsburgh), Donna Pickett(Centers for Disease Control and Prevention), Shannon McConnell-Lamptey(Centers for Disease Control and Prevention)
Cited by 9
Related Papers
The new International Classification of Diseases 11th edition: a comparative analysis with ICD-10 and ICD-10-CM
|Journal of the American Medical Informatics Association|2020|90
The carrier state for sickle cell disease is not completely harmless
|Haematologica|2019|82
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease
|Blood|2022|72
Paper-based microchip electrophoresis for point-of-care hemoglobin testing
|The Analyst|2020|71
Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease
|American Journal of Hematology|2018|39